WASSC Technologies

WASSC Technologies is a private Canadian biotechnology company based in Sherbrooke, Quebec, focused on antibody-drug conjugates, protein conjugation, and targeted drug delivery. The company develops manufacturing and optimization solutions for ADCs and appears to pair its internal technology platform with fee-for-service R&D work for bioconjugation and targeted therapy development. Publicly available descriptions indicate that its platform is intended to improve site-specific biomolecule conjugation, targeted delivery, and the effectiveness of vaccines and gene therapies. WASSC has also been cited as a collaborator to Defence Therapeutics on development of a small molecule for ADC applications. Available information suggests the company is still at a preclinical/platform stage rather than an advanced clinical-stage therapeutic developer.